Data from Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer

MLA

Héctor G. Palmer, et al. Data from Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.c.6524564.v1.

APA

Héctor G. Palmer, Josep Tabernero, Wenlin Shao, Ana Vivancos, Paolo Nuciforo, Ramón Charco, Eloy Espín, Aleix Prat, Stefania Landolfi, Jordi Rodon, Daniel Silberschmidt, Judit Matito, Ginevra Caratù, Natalia Fernández, Rodrigo Dienstmann, Guillem Argilés, Stephan P. Tenbaum, Isabel Puig, Irene Chicote, & Oriol Arqués. (2023). Data from Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer. https://doi.org/10.1158/1078-0432.c.6524564.v1

Chicago

Héctor G. Palmer, Josep Tabernero, Wenlin Shao, Ana Vivancos, Paolo Nuciforo, Ramón Charco, Eloy Espín, et al. 2023. “Data from Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer,” March. doi:10.1158/1078-0432.c.6524564.v1.